Profile | GDS4284 / 218136_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1826.14 | 83 |
GSM687648 | Patient 402 control | 1911.74 | 83 |
GSM687653 | Patient 403 control | 1508.91 | 80 |
GSM687658 | Patient 404 control | 2136.42 | 85 |
GSM687663 | Patient 411 control | 5240.74 | 94 |
GSM687668 | Patient 422 control | 3860.58 | 91 |
GSM687673 | Patient 424 control | 4804.68 | 93 |
GSM687678 | Patient 425 control | 3245.62 | 89 |
GSM687683 | Patient 427 control | 3526.18 | 90 |
GSM687688 | Patient 428 control | 1789.17 | 82 |
GSM687695 | Patient 441 control | 24407.2 | 99 |
GSM687699 | Patient 443 control | 4193.37 | 92 |
GSM687704 | Patient 444 control | 3264.72 | 90 |
GSM687707 | Patient 448 control | 1895.73 | 84 |
GSM687712 | Patient 449 control | 2333.82 | 86 |
GSM687719 | Patient 450 control | 4683.1 | 93 |
GSM687724 | Patient 451 control | 7664.43 | 96 |
GSM687728 | Patient 452 control | 11062.4 | 97 |
GSM687646 | Patient 401 treated 24h | 1802.74 | 82 |
GSM687649 | Patient 402 treated 24h | 1597.68 | 80 |
GSM687665 | Patient 411 treated 24h | 4813.12 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 2149.84 | 85 |
GSM687667 | Patient 411 treated 4 weeks | 3422.88 | 90 |
GSM687670 | Patient 422 treated 24h | 3773.87 | 91 |
GSM687671 | Patient 422 treated 4 weeks | 4331.85 | 92 |
GSM687654 | Patient 403 treated 24h | 1852.68 | 83 |
GSM687675 | Patient 424 treated 24h | 3738.72 | 91 |
GSM687685 | Patient 427 treated 24h | 3599.27 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 1774.46 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 3090.23 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 1553.73 | 80 |
GSM687692 | Patient 428 treated 4h | 1528.67 | 80 |
GSM687716 | Patient 449 treated 4h | 2076.15 | 84 |
GSM687722 | Patient 450 treated 4h | 5024.48 | 93 |
GSM687680 | Patient 425 treated 24h | 3413.01 | 90 |
GSM687690 | Patient 428 treated 24h | 1227.95 | 77 |
GSM687700 | Patient 443 treated 24h | 9893.78 | 97 |
GSM687705 | Patient 444 treated 24h | 2265.16 | 86 |
GSM687714 | Patient 449 treated 24h | 2445.84 | 86 |
GSM687721 | Patient 450 treated 24h | 4953.67 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 3697.12 | 91 |
GSM687694 | Patient 428 treated 4 weeks | 2442.5 | 86 |
GSM687702 | Patient 443 treated 4 weeks | 4701.53 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 2319.76 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2749.62 | 88 |
GSM687661 | Patient 404 treated 4h | 1762.75 | 82 |
GSM687710 | Patient 448 treated 4h | 2492.19 | 87 |
GSM687726 | Patient 451 treated 4h | 8247.36 | 96 |
GSM687730 | Patient 452 treated 4h | 1626.65 | 82 |
GSM687660 | Patient 404 treated 24h | 1856.76 | 85 |
GSM687697 | Patient 441 treated 24h | 14049.6 | 98 |
GSM687709 | Patient 448 treated 24h | 2303.01 | 86 |
GSM687725 | Patient 451 treated 24h | 7695.02 | 96 |
GSM687729 | Patient 452 treated 24h | 12782.2 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 5369.2 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 7227.42 | 96 |